Patient Access
How patients obtain medical cannabis through licensed clinics and specialist prescribers.
Patient Access · page 4
- Clinical Research
Cannabis Health Symposium 2025 – Key Takeaways Part 2
The afternoon sessions at Tuesday’s inaugural Cannabis Health Symposium 2025 moved beyond the fundamentals of cannabis medicine and its potential, to the practical realities of prescribing this relatively new medicine in the UK.
- Clinical Research
Cannabis Health Symposium 2025 – Key Takeaways Part 1
On Tuesday, November 25, nearly 200 healthcare professionals, patient advocates, cannabis educators, and industry leaders converged on London’s Conway Hall for the inaugural Cannabis Health Symposium.
- Medical Cannabis
Patients Make History at First Educational Event on Cannabis-Based Medicines in London
First published on Cannabis Health Medical cannabis patients made history in London with a first-of-its-kind, patient-led education event focused on cannabis-based medicines, hosted at the Charterhouse.
- Clinical Research
Accredited Medical Cannabis Symposium Could ‘Benefit Thousands of Patients’, Says Expert
Accredited Medical Cannabis Symposium Could ‘Benefit Thousands of Patients’, Says Expert
- Medical Cannabis
ACCM Launches National Partnerships to Expand Medical Cannabis Access and Insurance Coverage
The American Council of Cannabis Medicine (ACCM) has announced the launch of a new nationwide initiative with major insurers, healthcare systems, and associations to expand affordable access to medically guided cannabis treatment across the United States.
- International Regulation
Inside Australia’s Medical Cannabis Boom: Prescriptions, Products & Patients
Australia’s thriving medical cannabis industry has continued its blistering levels of growth, seeing the amount of medical cannabis imported grow nearly tenfold in just three years, according to new official data.
- Legal Analysis
How Has the UK Government’s Position on Cannabis Changed Under Labour?
The UK’s cannabis industry, one of the largest on the planet, sits at a crossroads.
- Legal Analysis
£13.3 Billion Boost: Medical Cannabis Expansion Touted as Solution to NHS Woes
Expanding NHS access to medical cannabis could add £13.3bn to the UK economy over 10 years, easing NHS costs and reducing long-term sickness.
- Industry Trends
Patients, Companies and Platforms Oppose Tightening of the CanG
Parts of the German federal government are dissatisfied with the current interpretation of the Cannabis Act (CanG), introduced by the previous traffic-light coalition, which marked a paradigm shift in cannabis policy.
- Medical Cannabis
Implementation Questionable: Federal Drug Commissioner Calls for Stricter Rules on Cannabis Medicine
This article is also available in German Germany’s new Federal Drug Commissioner, Prof Dr Hendrik Streeck (CDU), who in June had spoken only vaguely about the partial legalisation of cannabis, has since taken a sharper stance.
- Medical Cannabis
Inside Slovenia’s New ‘Revolutionary’ Medical Cannabis Law
Last month, Slovenia’s parliament passed a law to significantly open up access to medical cannabis, coinciding with the presentation of a separate draft law on legalisation for personal use.
- Medical Cannabis
German Health Insurance Companies No Longer Want to Cover the Costs of Cannabis Flower
In Germany, the partial legalisation of cannabis has opened up a new telemedicine market. Instead of visiting a doctor in person, patients can now request prescriptions online, with cannabis flowers sent directly to patients via specialist pharmacies.
